TY - CHAP
T1 - Unique considerations when managing hypertension in the transplant patient
AU - Mitema, Donald
AU - Schinstock, Carrie
N1 - Publisher Copyright:
© Springer International Publishing AG 2016.
PY - 2017
Y1 - 2017
N2 - For the select fortunate recipients of organ transplants, transplantation affords the rare opportunity for a new life. Given the scarcity of organs for transplantation, it is imperative that the health of transplant recipients be optimized in order to fully benefit from this gift of life. Unfortunately, hypertension is highly prevalent in the transplant population and it is considered a major cardiovascular risk factor contributing to mortality and morbidity in this population. In this chapter, we expound on the epidemiology, unique pathophysiology, evaluation, and management of hypertension as it pertains to the solid organ transplant recipient. In addition, a brief commentary is made on the subject of hypertension following living kidney donation, and practical aspects of management of hypertension in the solid organ recipient are summarized at the end of the chapter.
AB - For the select fortunate recipients of organ transplants, transplantation affords the rare opportunity for a new life. Given the scarcity of organs for transplantation, it is imperative that the health of transplant recipients be optimized in order to fully benefit from this gift of life. Unfortunately, hypertension is highly prevalent in the transplant population and it is considered a major cardiovascular risk factor contributing to mortality and morbidity in this population. In this chapter, we expound on the epidemiology, unique pathophysiology, evaluation, and management of hypertension as it pertains to the solid organ transplant recipient. In addition, a brief commentary is made on the subject of hypertension following living kidney donation, and practical aspects of management of hypertension in the solid organ recipient are summarized at the end of the chapter.
KW - Blood pressure in solid organ transplant recipients
KW - Calcineurin inhibitors
KW - Hypertension
KW - Post-transplant hypertension
UR - http://www.scopus.com/inward/record.url?scp=85019255474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019255474&partnerID=8YFLogxK
U2 - 10.1007/5584_2016_87
DO - 10.1007/5584_2016_87
M3 - Chapter
C2 - 27815930
AN - SCOPUS:85019255474
T3 - Advances in Experimental Medicine and Biology
SP - 341
EP - 353
BT - Advances in Experimental Medicine and Biology
PB - Springer New York LLC
ER -